Casper Steenholdt - Concepedia

Author

Casper Steenholdt

Herlev Hospital ORCID

Also Known As

C Steenholdt, C. Steenholdt, Casper Steenholdt, Steenholdt, C.

151

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Herlev Hospital Rigshospitalet Copenhagen University Hospital Odense University Hospital University of Copenhagen

About

Casper Steenholdt is an author at Herlev Hospital specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	598
2	Allergy	4	4	214
3	Engineering	1	1	13
4	Public Health	1	1	34
5	Anesthesia	1	1	31

Casper Steenholdt

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, Gut	2013	451
Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease Casper Steenholdt, Klaus Bendtzen, Jørn Brynskov, Scandinavian Journal of Gastroenterology	2010	173
Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease Casper Steenholdt, Morten Svenson, Klaus Bendtzen, Alimentary Pharmacology & Therapeutics	2011	143
Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial Casper Steenholdt, Klaus Bendtzen, Jørn Brynskov, The American Journal of Gastroenterology	2014	134
Doubling the infliximab dose versus halving the infusion intervals in Crohnʼs disease patients with loss of response Lior H. Katz, Javier P. Gisbert, Beth Manoogian, Inflammatory Bowel Diseases	2012	130
Comparison of Techniques for Monitoring Infliximab and Antibodies Against Infliximab in Crohn's Disease Casper Steenholdt, Mark Ainsworth, Michaël G. Tovey, Therapeutic Drug Monitoring	2013	114
Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls Louise Kristine Vigsnæs, Jørn Brynskov, Casper Steenholdt, Beneficial Microbes ProbioticGram-negative BacteriologyDysbiosisMedicineGut Microbiology	2012	108
Antibodies Against Infliximab Are Associated with De Novo Development of Antibodies to Adalimumab and Therapeutic Failure in Infliximab-to-Adalimumab Switchers with IBD M. Frederiksen, Mark Ainsworth, Jørn Brynskov, Inflammatory Bowel Diseases	2014	105
Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease Casper Steenholdt, Magid A R Al-Khalaf, Jrn Brynskov, Inflammatory Bowel Diseases	2012	102
Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists Christophe Lallemand, Nadia Kavrochorianou, Casper Steenholdt, Journal of Immunological Methods Tnfα AntagonistsAllergyReporter Gene AssayImmunologyImmune Surveillance	2011	94

Page 1